4//SEC Filing
PERNIX THERAPEUTICS HOLDINGS, INC. 4
Accession 0001354488-14-001473
CIK 0001024126operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:01 PM ET
Size
9.7 KB
Accession
0001354488-14-001473
Insider Transaction Report
Form 4
Smith James Edward Jr.
Director10% Owner
Transactions
- Sale
Common Stock
2014-03-26$5.52/sh−15,000$82,796→ 4,732,704 total - Sale
Common Stock
2014-03-28$5.42/sh−15,000$81,270→ 4,702,704 total - Sale
Common Stock
2014-03-27$5.46/sh−15,000$81,954→ 4,717,704 total
Holdings
- 3,200(indirect: By daughter)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/3/14.
- [F2]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.29 to $5.78, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.78, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.54, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
PERNIX THERAPEUTICS HOLDINGS, INC.
CIK 0001024126
Entity typeoperating
IncorporatedMD
Related Parties
1- filerCIK 0001024126
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:01 PM ET
- Size
- 9.7 KB